ORBIMED ADVISORS LLC

13F Portfolio Filings

Most recent 13F
Q2 2026
13D/G filings
13D on 24 securities, 13G on 18 securities
Location
New York, NY
CIK
0001055951
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q2 2026 129 5,396,779 EWTX, ELVN, LLY, MBX 13F-HR 8/14/2026 000117266126003740
Q1 2026 114 5,045,363 EWTX, ELVN, MDXH calls, LLY 13F-HR 5/15/2026 000117266126002369
Q4 2025 108 4,899,391 EWTX, LLY, BSX, SVA 13F-HR 2/17/2026 000117266126001119
Q3 2025 110 4,255,380 EWTX, BSX, LLY, SVA 13F-HR 11/14/2025 000117266125005047
Q2 2025 103 4,004,110 SVA, BSX, LLY, EWTX 13F-HR 8/14/2025 000117266125003514
Q1 2025 111 4,194,646 SVA, EWTX, BSX, LLY 13F-HR 5/15/2025 000117266125002355
Q4 2024 119 4,861,409 EWTX, SVA, BSX, LLY 13F-HR 2/14/2025 000117266125001136
Q3 2024 119 5,503,519 EWTX, SVA, LLY, BSX 13F-HR 11/14/2024 000117266124005167
Q2 2024 115 5,064,526 SVA, LLY, EWTX, BSX 13F-HR 8/14/2024 000117266124003539
Q1 2024 115 5,459,959 SVA, LLY, EWTX, BSX 13F-HR 5/15/2024 000117266124002506
Q4 2023 111 5,007,244 SVA, BIIB, LLY, BSX 13F-HR 2/14/2024 000117266124001461
Q3 2023 128 4,707,565 SVA, BSX, HUM, ISRG 13F-HR 11/14/2023 000117266123004019
Q2 2023 127 5,518,910 SVA, ISRG, ELVN, BSX 13F-HR 8/14/2023 000117266123003177
Q1 2023 125 5,094,046 SVA, ELVN, BSX, HUM 13F-HR 5/15/2023 000117266123002323
Q4 2022 116 5,227,458 SVA, UNH, BMY, BSX 13F-HR 2/14/2023 000117266123001310
Q3 2022 132 5,387,000 SVA, BMY, HUM, SWTX 13F-HR 11/14/2022 000117266122002553
Q2 2022 145 5,518,815 SVA, BMY, HUM, HZNP 13F-HR 8/15/2022 000117266122001998
Q1 2022 145 6,167,262 SWTX, HZNP, BSX, PFE 13F-HR 5/16/2022 000117266122001456
Q4 2021 159 7,778,455 SWTX, BMY, HZNP, BSX 13F-HR 2/14/2022 000117266122000795
Q3 2021 173 9,099,330 SWTX, PRLD, HZNP, MRK 13F-HR 11/15/2021 000117266121002332
Q2 2021 160 9,886,767 SWTX, BMY, EWTX, BSX 13F-HR 8/16/2021 000117266121001841
Q1 2021 159 10,694,926 SWTX, EWTX, PRLD, SPRY 13F-HR 5/17/2021 000117266121001345
Q4 2020 149 11,428,040 PRLD, SWTX, PMVP, SPRY 13F-HR 2/16/2021 000117266121000786
Q3 2020 143 7,956,183 PRLD, SWTX, PMVP, ALXN 13F-HR 11/16/2020 000117266120002295
Q2 2020 135 7,102,993 SWTX, TCDAQ, ALXN, ASND 13F-HR 8/14/2020 000117266120001859
Q1 2020 142 5,950,362 ASND, TCDAQ, ALEC, SWTX 13F-HR 5/15/2020 000117266120001407
Q4 2019 136 7,004,336 ASND, THOR, TCDAQ, SWTX 13F-HR 2/14/2020 000117266120000859
Q3 2019 116 5,269,963 ASND, TCDAQ, BSX, ALEC 13F-HR 11/14/2019 000117266119002352
Q2 2019 128 6,457,032 ASND, TCDAQ, BSX, ALXN 13F-HR 8/14/2019 000117266119001883
Q1 2019 124 6,459,711 ASND, TCDAQ, CMTA, ALXN 13F-HR 5/15/2019 000117266119001382
Q4 2018 131 5,407,812 TCDAQ, ASND, BIIB, CELG 13F-HR 2/14/2019 000117266119000868
Q3 2018 150 8,302,401 ALXN, TCDAQ, BIIB, VRTX 13F-HR 11/14/2018 000117266118002168
Q2 2018 147 8,384,406 ALXN, BIIB, TCDAQ, BSX 13F-HR 8/14/2018 000117266118001660
Q1 2018 141 8,065,259 ALXN, REGN, VRTX, MRK 13F-HR 5/15/2018 000117266118001239
Q4 2017 133 7,905,721 BIIB, ALXN, REGN, CELG 13F-HR 2/14/2018 000117266118000795
Q3 2017 143 10,463,804 ALXN, BIIB, CELG, BSX 13F-HR 11/14/2017 000117266117002146
Q2 2017 138 9,540,384 ALXN, CELG, BIIB, BSX 13F-HR 8/14/2017 000117266117001699
Q1 2017 136 8,822,204 ALXN, BIIB, CELG, BSX 13F-HR 5/15/2017 000117266117001216
Q4 2016 132 7,848,022 ALXN, BIIB, CELG, BSX 13F-HR 2/14/2017 000117266117000766
Q3 2016 140 8,780,843 BIIB, BSX, AMGN, ALXN 13F-HR 11/14/2016 000117266116004318
Q2 2016 137 9,583,046 BSX, AMGN, ABBV, BMY 13F-HR 8/15/2016 000117266116003893
Q1 2016 141 9,503,629 BMY, HCA, AMGN, BSX 13F-HR 5/16/2016 000117266116003439
Q4 2015 130 11,043,258 BMY, AMGN, BSX, AGN 13F-HR 2/16/2016 000117266116002937
Q3 2015 132 9,905,986 BMY, HCA, AMGN, BSX RESTATEMENT 11/18/2015 000117266115002104
Q2 2015 1 1,664,037 BONE NEW HOLDINGS 8/20/2015 000117266115001668
Q2 2015 136 11,964,202 BIIB, BMY, AGN, HCA 13F-HR 8/14/2015 000117266115001654
Q1 2015 135 11,714,377 BMY, BIIB, AMGN, ACT 13F-HR 5/15/2015 000117266115001221
Q4 2014 131 10,464,861 BIIB, BMY, AMGN, CELG 13F-HR 2/13/2015 000117266115000419
Q3 2014 130 9,573,927 GILD, BIIB, BMY, AMGN 13F-HR 11/14/2014 000117266114001849
Q2 2014 132 8,516,434 ICPT, BMY, BIIB, ABBV 13F-HR 8/14/2014 000117266114001491
Q1 2014 140 8,131,588 ICPT, GILD, BIIB, BMY 13F-HR 5/15/2014 000117266114001118
Q4 2013 120 6,804,448 GILD, BIIB, CELG, BMY 13F-HR 2/14/2014 000117266114000746
Additional filings from Orbimed Advisors LLC that have since been restated

13D and 13G Filings

All 13D and 13G filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each security where the latest filing since 12/18/2024 is a 13D, newest first.

Issuer % of Class Filed
ArriVent BioPharma, Inc. 13D/A
AVBP · 04272N102
 5.8% 10/8/2026
Event 10/6/2026
ADARx Pharmaceuticals, Inc. 13D
00654F105
 14.0% 10/2/2026
Event 9/28/2026
Electra Therapeutics, Inc. 13D
284825106
 11.0% 9/25/2026
Event 9/21/2026
Braveheart Bio, Inc. 13D/A
BRVE · 10567X101
 13.5% 9/10/2026
Event 9/8/2026
BlossomHill Therapeutics, Inc. 13D
BLSM · 095130100
 8.9% 8/18/2026
Event 8/10/2026
MBX Biosciences, Inc. 13D/A
MBX · 55287L101
 6.4% 8/10/2026
Event 8/6/2026
Yarrow Bioscience, Inc. 13D
YARW · 92941V407
 10.0% 8/5/2026
Event 7/27/2026
Scribe Therapeutics, Inc. 13D
SCTX · 811033109
 7.2% 7/29/2026
Event 7/27/2026
Q32 Bio Inc. 13D/A
QTTB · 746964105
 13.9% 7/20/2026
Event 7/16/2026
Enliven Therapeutics, Inc. 13D/A
ELVN · 29337E102
 9.5% 6/24/2026
Event 6/22/2026
Shattuck Labs, Inc. 13D/A
STTK · 82024L103
 10.0% 6/15/2026
Event 6/11/2026
Traws Pharma, Inc. 13D/A
TRAW · 68232V884
 11.9% 5/5/2026
Event 4/16/2026
ImageneBio, Inc. 13D/A
IKNA · 45175G108
 13.1% 4/29/2026
Event 4/14/2026
Prelude Therapeutics Inc 13D/A
PRLD · 74065P101
 16.0% 4/23/2026
Event 4/21/2026
Sionna Therapeutics, Inc. 13D/A
SION · 829401108
 6.6% 4/20/2026
Event 4/15/2026
Adicet Bio, Inc. 13D/A
ACET · 007002108
 8.8% 4/10/2026
Event 4/8/2026
Corvus Pharmaceuticals, Inc. 13D/A
CRVS · 221015100
 10.3% 1/27/2026
Event 1/23/2026
Compass Therapeutics, Inc. 13D/A
CMPX · 20454B104
 8.9% 8/15/2025
Event 8/13/2025
Edgewise Therapeutics, Inc. 13D/A
EWTX · 28036F105
 14.5% 5/12/2025
Event 5/9/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
PMV Pharmaceuticals, Inc. 13D/A
PMVP · 69353Y103
 0% 3/4/2026
Event 3/2/2026
Terns Pharmaceuticals, Inc. 13D/A
TERN · 880881107
 4.8% 11/5/2025
Event 11/3/2025
Passage BIO, Inc. 13D/A
PASG · 702712100
 4.3% 7/24/2025
Event 7/22/2025
Xtant Medical Holdings, Inc. 13D/A
XTNT · 98420P308
 0% 4/14/2025
Event 4/10/2025
Disc Medicine, Inc. 13D/A
IRON · 254604101
 4.5% 3/12/2025
Event 3/10/2025

18 other securities where the latest filing is a 13G, the newest filed 8/14/2026. View all